Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Dermatology/Plastic Surgery
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Dermik Laboratories
Approval Status: Approved January 1998
Treatment Area: Rosacea
Noritate (metronidazole cream) 1% has been approved as a topical
rosacea therapy for the treatment of inflammatory lesions and
erythema (facial redness) associated with the condition.
Noritate has been shown to significantly reduce inflammatory
lesions of rosacea in as little as four weeks with minimal skin
dryness and irritation.